Sign Up to like & get
recommendations!
2
Published in 2022 at "Blood"
DOI: 10.1182/blood.2022018602
Abstract: Myelodysplastic Neoplasms (MDS) and Chronic Myelomonocytic Leukemia (CMML) are clonal disorders driven by progressively acquired somatic mutations in hematopoietic stem cells (HSCs). Hypomethylating agents (HMA) can modify the clinical course of MDS and CMML. Clinical…
read more here.
Keywords:
immature mature;
mature cells;
progenitor;
mds cmml ... See more keywords